Athersys Inc (NASDAQ: ATHX) is headed for the top in the market this morning, and for good reason. The company announced that its partner, HEALIOS, has released topline positive data from a clinical trial in patients with COVID-induced ARDS. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! … Read more
Athersys, Inc. (NASDAQ: ATHX) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it has entered into an agreement to expand its collaboration with HEALIOS K.K. (Healios). Of course, the news excited investors, sending the stock screaming for the top. … Read more
Athersys, Inc. (NASDAQ: ATHX) is having yet another strong start to the trading session in the market today after announcing earnings. This comes after yesterday’s early morning announcement surrounding the expansion of MultiStem®. Of course, the financial results proved to be positive, leading to further excitement that’s sending the stock higher in the market this morning. … Read more
Athersys, Inc. (NASDAQ: ATHX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced news surrounding an expanded collaboration surrounding a key product. Of course, this led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about the news, what we’re seeing … Read more
Athersys, Inc. (NASDAQ: ATHX) is having a pretty strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced a new equity facility that opens the door to funding. This announcement ultimately led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about … Read more
Athersys, Inc. (NASDAQ: ATHX) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that a Phase 3 trial design received positive views from the EMA. As a result, investor excitement ensued, leading to gains and prompting our partners at Trade Ideas … Read more
Athersys, Inc. (NASDAQ: ATHX) This article was available to premium members 48 hours before the public. Okay, Soulstring Nation, we are now delivering on 23 of the last 24 stocks featured in my weekly opine. Coming off last week’s massive 24% increase in Biohaven (BHVN), this week’s stock may offer just as much firepower as … Read more
Okay, Soulstring Nation, we are now delivering on 23 of the last 24 stocks featured in my weekly opine. Coming off last week’s massive 24% increase in Biohaven (BHVN), this week’s stock may offer just as much firepower as BHVN, and it’s certainly time that the market appreciates the value of this innovative and fast … Read more
Athersys, Inc. (NASDAQ: ATHX) Athersys is having an incredibly strong day in the market today. After starting the day off in the red, the stock started moving upward as soon as the opening bell rang. Since then, we’ve seen a continuation of strong movement, bringing the stock well into the green. Below, we’ll talk about … Read more
Athersys, Inc. (NASDAQ: ATHX) Athersys (ATHX) is an international biopharmaceutical company engaged in the discovery and development of therapies designed to extend and enhance the quality of human life. Athersys’ lead product development programs utilize MultiStem®, a proprietary “off the shelf” stem cell product that has shown promise for treating indications in the neurological, cardiovascular … Read more